Stocks
📈 Shares of biopharmaceutical Pfizer (+5.1%) are up. The company's quotes are rising after the FDA (U.S. Food and Drug Administration) meeting, which granted approval for booster doses of the COVID-19 vaccine for children in emergencies. However, it is unlikely that this will lead to any additional orders for